MondayNov 29, 2021 11:40 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Notes Adelia Milestone Achievements

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has reported that its wholly controlled subsidiary, Adelia Therapeutics Inc., has achieved key milestones. The milestones were outlined in the agreement between Cybin, Cybin Corp., Cybin US Holdings Inc. and the previous shareholders of Adelia. Based on the agreement, 31,721.5 class B common shares of the company will be issued to Adelia shareholders as a result of relevant milestones being met. Adelia develops medicinal psychedelics designed to provide improved dosing efficacy and therapeutic indices that address unmet medical needs. The company’s primary focus is on the…

Continue Reading

MondayNov 29, 2021 11:33 am

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Featured in Latest Market Herald Interview

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, is spotlighted in a recent Power Play interview released by the Market Herald. FuelPositive CEO Ian Clifford talked with Power Play’s Dave Jackson during the interview, down with CEO Ian Clifford to discuss NHHHF’s recent announcement of its operational costing model and timeline for a green ammonia production system. Clifford noted that the company’s initial systems are estimated to produce up to 100 tons of green anhydrous ammonia per year at a cost of C$560 per metric ton. The company plans…

Continue Reading

MondayNov 29, 2021 10:43 am

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Report on 2021 Shareholder General and Special Meeting

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, announced that at its annual general and special meeting of shareholders (“AGM”) all agenda items were approved. The meeting was held on Nov. 24, 2021. Included in the agenda items were the election of directors and the appointment of an auditor. According to the company, four individuals were elected to the board, including Marcello Leone, John Campbell, Martino Ciambrelli and Phil Fontaine. In addition, Dale Matheson Carr-Hilton Labonte LLP (“DMCL”) was reappointed as the company auditor for the next year. To view…

Continue Reading

MondayNov 29, 2021 9:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Schedules November 29th for Q3 2021 Financials Release; November 30th for Earnings Discussion

RWB is set to release its Q3 financial results on November 29, 2021 A conference call will follow this release on November 30, 2021, at 5:00 PM ET to discuss these results, the company’s operations, upcoming events, and a Q&A session A replay of the call will be available for 90 days, starting three hours after the conclusion RWB is increasingly optimistic about its Q3 performance following growth in revenue from Q1 to Q2, along with strategic investments that would allow for Q3 growth Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) just announced that it will be releasing…

Continue Reading

MondayNov 29, 2021 9:30 am

RYAH Group Inc. (CSE: RYAH) Releases Overview of UK Cannabis Market

Market analysts place high hopes on the potential of the United Kingdom market Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence After three years of medical cannabis being legal in the United Kingdom, the country has a total of only three patients with a prescription in the entire public system, noted a recent blog from RYAH Group (CSE: RYAH). The article noted that many more patients receive cannabis-derived medications, including flower and cannabis oil,…

Continue Reading

MondayNov 29, 2021 9:30 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands Marketing Reach, Offers Discounts, Through New Subscription Service

Plant-based food consumers are a growing market sector, increasing their purchases at a rate almost 2.5 times the growth of the overall foods market during the past two years Plant-based community brand builder PlantX Life Inc. is becoming a growing global presence as part of its efforts to become a one-stop shopping source of products and information about the plant-based lifestyle PlantX has physical store presence in Canada and the U.S., as well as one in Israel that will open before the end of the year The company’s e-commerce platform recently added a subscription service that caters to recurring customer…

Continue Reading

MondayNov 29, 2021 9:28 am

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Releases Financial, Operations Report for Latest Period

AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, has reported its unaudited financial results and business highlights for the nine months ended Sept. 30, 2021. Financial highlights include total revenue reaching an estimated  $2.1 million, which is a 55.3% over the same period in 2020, and gross profit margin totaling 59.3%, representing an 8.8% increase from the year before. In addition, the average selling price of ANPC’s CDA-based tests was $71.6,  an increase of 72.3% from 2020. In addition, the company reported cash and cash…

Continue Reading

MondayNov 29, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Psilocybin Drug Program for the Treatment of Pain and Eating Disorders Takes On Special Meaning Leading Up To The Holidays

People with eating disorders know all about the difficulties faced during holiday celebrations and their association with heavy eating The fall-winter holiday season can also adversely affect people suffering from certain chronic pains, as temperatures and pressure changes can increase pain sensitivity Tryp is looking to help alleviate problems associated with eating disorders and chronic pain through its psilocybin-based drug program that focuses on conditions with high unmet needs The company has submitted several IND applications for Phase 2a studies evaluating TRP-8802’s effectiveness in patients with chronic pain and select eating disorders There is no denying that food is a…

Continue Reading

MondayNov 29, 2021 9:00 am

Insurtech Market Seen as a Major Driver for Big Data and Mobile Tech Innovator FingerMotion Inc. (FNGR)

U.S.-based FingerMotion is a technology innovator focused on smart communication applications in China’s mobile-hungry billion-plus population The company’s big data services are relatively new in development but already play a significant role in the insurtech industry’s global growth trends While most of FingerMotion’s revenues are derived from its SMS and MMS products, executives anticipate its big data services will eventually be the company’s largest driver of profits The insurtech industry has already generated record annual deal-making this year as of the third quarter, outpacing all of 2020 by 48 percent The insurtech industry has turned 2021 into a record year…

Continue Reading

MondayNov 29, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs

InMed Pharmaceuticals released Q1 2022 financial results in which it reported a year-on-year increase in research and development expenses primarily due to increased activities related to INM-755 clinical trials The company’s cash, cash equivalents, and short-term investments also grew quarter over quarter from $7.4 million to $15.4 million Following the closing of BayMedica’s acquisition, the integrated teams are working together with a focus on launching selected rare cannabinoids, growing revenue, and expanding sales InMed has commenced Phase 2 clinical trial of INM-755 (cannabinol) cream for the treatment of a group of rare skin disorders Preclinical data of INM-088, the company’s…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered